Encounter for screening for malignant neoplasm of breast
ICD-10 Z12.3 is a billable code used to indicate a diagnosis of encounter for screening for malignant neoplasm of breast.
Z12.3 is used to indicate an encounter for screening for malignant neoplasm of the breast, primarily aimed at early detection of breast cancer in asymptomatic individuals. This screening is crucial as it can lead to earlier diagnosis and treatment, significantly improving patient outcomes. Factors influencing health status include access to healthcare services, socioeconomic status, and education level, which can affect a patient's likelihood of participating in preventive screenings. Social determinants such as race, ethnicity, and geographic location also play a role in screening rates. Preventive care through regular screenings is essential, particularly for women over the age of 40 or those with a family history of breast cancer. The code is applicable in various healthcare settings, including outpatient clinics, hospitals, and community health programs, emphasizing the importance of routine screenings in public health initiatives.
Documentation must include patient history, risk factors, and consent for screening.
Routine checkups where screening is discussed and performed.
Consideration of social determinants such as access to care and patient education.
Population-level data collection and tracking of screening rates.
Community health initiatives aimed at increasing screening participation.
Focus on health disparities and outreach to underserved populations.
Used in conjunction with Z12.3 for routine screening mammograms.
Documentation of the screening indication and patient consent.
Primary care providers should ensure patients understand the importance of screening.
Documentation must include the patient's age, risk factors, consent for screening, and any relevant medical history. It is also important to note if the screening was performed and the results.
